内容摘要：“Being able to come back in no matter what the scenario was and being able to have the resiliency in me is something I can be proud of,” Skinner said. “So much of it has to do with how the guys are playing in front of me. The way they’ve played ever since I’ve come back in is impressive.”

“Being able to come back in no matter what the scenario was and being able to have the resiliency in me is something I can be proud of,” Skinner said. “So much of it has to do with how the guys are playing in front of me. The way they’ve played ever since I’ve come back in is impressive.”

Health Secretary Robert F. Kennedy Jr. has called the federal dietary guidelines requiringand last month encouraged “full fat/whole milk” to be used in Head Start programs for the nation’s youngest children.

AP’s Lisa Dwyer reports there’s a new push to put whole milk back in school meals.The Obama-era move to requirewas aimed at cutting kids’ consumption of saturated fat and calories, which can increase the risk of heart disease and obesity.

But some nutrition experts, lawmakers and the dairy industry argue that whole milk has been unfairly vilified, and that some studies suggest kids who drink whole milk are less likely to have obesity. Critics also contend that many children don’t like the taste of lower-fat milk and don’t drink it, leading them to miss valuable nutrients.Here’s what you need to know about the debate over whole milk in school meals:

In 2010, Congress passed the Healthy, Hunger-Free Kids Act, which aimed to reduce childhood obesity and cut health risks for kids. It required school meals to include more whole grains, fruits and vegetables, protein and low-fat dairy and less sugar, sodium and fat.

Starting in 2012, whole and 2% milk was not permitted in school meals because those products are higher in saturated fat and calories than lower-fat options.Genetic testing companies such as GeneDx have made some headway in screening more people of diverse backgrounds, but inequities remain.

For example, comprehensive data about cystic fibrosis is scarce among African populations – affecting people who live on the continent as well as those who trace their ancestry there.Black cystic fibrosis patients are more likely than their white counterparts to be among the 10% who don’t benefit from modulator therapies.

While there’s little chance of changing market dynamics, researchers said, one solution is to develop “mutation agnostic” gene therapies targeting all patients with a disease. This approach is being tried in diseases of the retina as well as cystic fibrosis.“There’s a huge push to develop these therapies,” said Dr. Garry Cutting of the Johns Hopkins Cystic Fibrosis Center.